DIGITAL THERAPEUTICS

Owner

Goods & Services

scientific research and development in the fields of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics, namely, selection, preparation, analysis, modification, synthesization and delivery of mRNA by chemical, biological and biochemical means, and none of the foregoing research and development services pertaining to the use of digital technology designed to affect behavior or lifestyle changes or the use of digital technology to monitor dosing compliance or improve health outcomes other than by administration of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics